46th week of 2017 patent applcation highlights part 22 |
Patent application number | Title | Published |
20170327501 | CARBOXAMIDE DERIVATIVES USEFUL AS RSK INHIBITORS | 2017-11-16 |
20170327502 | IMIDAZOTRIAZINONE COMPOUNDS | 2017-11-16 |
20170327503 | OPTIONALLY FUSED HETEROCYCLYL-SUBSTITUTED DERIVATIVES OF PYRIMIDINE USEFUL FOR THE TREATMENT OF INFLAMMATORY, METABOLIC, ONCOLOGIC AND AUTOIMMUNE DISEASES | 2017-11-16 |
20170327504 | Synthesis of Substituted 1H-Pyrazolo[3,4-D]Pyrimidines | 2017-11-16 |
20170327505 | SYNTHESIS OF COPANLISIB AND ITS DIHYDROCHLORIDE SALT | 2017-11-16 |
20170327506 | 6-AMINO-7-BICYCLO-7-DEAZA-PURINE DERIVATIVES AS PROTEIN KINASE INHIBITORS | 2017-11-16 |
20170327507 | PROCESS FOR THE PREPARATION OF BARICITINIB AND AN INTERMEDIATE THEREOF | 2017-11-16 |
20170327508 | DEUTERATED HETEROARYL SULFONAMIDES AND THEIR USE | 2017-11-16 |
20170327509 | TWO-PHOTON ABSORBING FLUOROPHORES AND METHOD FOR CELLULAR IMAGING USING THE SAME | 2017-11-16 |
20170327510 | PHTHALOCYANINE COMPOUND AND METHOD OF PREPARING THE SAME, COLOR FILTER CONTAINING PHTHALOCYANINE COMPOUND, AND COLORING COMPOSITION | 2017-11-16 |
20170327511 | PROCESS FOR THE FORMATION OF HYDROCODONE BITATRATE | 2017-11-16 |
20170327512 | MODULATORS OF VASOPRESSIN RECEPTORS WITH THERAPEUTIC POTENTIAL | 2017-11-16 |
20170327513 | OXAZIRIDINE COMPOUND AND PRODUCTION METHOD THEREOF | 2017-11-16 |
20170327514 | FLAP MODULATORS | 2017-11-16 |
20170327515 | Broad Spectrum Beta-Lactamase Inhibitors | 2017-11-16 |
20170327516 | Method for Producing an Organic Electronic Component, and Organic Electronic Component | 2017-11-16 |
20170327517 | Boronic Acid Inhibitors of HIV Protease | 2017-11-16 |
20170327518 | COMPOUND FOR LABELING MITOCHONDRIA AND METHOD OF PRODUCING THE SAME | 2017-11-16 |
20170327519 | OXABOROLE ESTERS AND USES THEREOF | 2017-11-16 |
20170327520 | CONJUGATED BISPHOSPHONATES FOR THE DIAGNOSIS AND THERAPY OF BONE DISEASES | 2017-11-16 |
20170327521 | PHOSPHAPLATIN COMPLEXES AND METHODS FOR TREATMENT OF PROLIFERATIVE DISEASES USING THE PHOSPHAPLATIN COMPLEXES | 2017-11-16 |
20170327522 | PROLIFERATIVE DISEASE TREATMENT METHODS WITH PHOSPHAPLATIN COMPLEXES | 2017-11-16 |
20170327523 | METHOD OF COALESCING A SUBSTANCE | 2017-11-16 |
20170327524 | GALNAC PHOSPHORAMIDITES, NUCLEIC ACID CONJUGATES THEREOF AND THEIR USE | 2017-11-16 |
20170327525 | SELECTED MACROLIDES WITH PDE4-INHIBITING ACTIVITY | 2017-11-16 |
20170327526 | 2'-CHLORO AMINOPYRIMIDINONE AND PYRIMIDINE DIONE NUCLEOSIDES | 2017-11-16 |
20170327527 | METHOD FOR SOLUTION PHASE DETRITYLATION OF OLIGOMERIC COMPOUNDS | 2017-11-16 |
20170327528 | 6-ALKYL-7-HYDROXY-4-EN-3-ONE STEROIDS AS INTERMEDIATES FOR THE PRODUCTION OF STEROIDAL FXR | 2017-11-16 |
20170327529 | 20(R)-GINSENOSIDE RG3 POLYACYLATED DERIVATIVES, PREPARATION AND APPLICATION THEREOF | 2017-11-16 |
20170327530 | METHODS OF TREATING AND PREVENTING GASTROINTESTINAL MOTILITY DISORDERS USING AMINOSTEROLS | 2017-11-16 |
20170327531 | 6.ALPHA.-ALKYL-6,7-DIONE STEROIDS AS INTERMEDIATES FOR THE PRODUCTION OF STEROIDAL FXR MODULATORS | 2017-11-16 |
20170327532 | METHODS, COMPOSITIONS, AND KITS USING HETEROGENEOUS CATALYSTS | 2017-11-16 |
20170327533 | METHOD FOR SPECIFIC CLEAVAGE OF C Alpha-C BOND AND SIDE CHAIN OF PROTEIN AND PEPTIDE, AND METHOD FOR DETERMINING AMINO ACID SEQUENCE | 2017-11-16 |
20170327534 | SEPARATION MATRIX | 2017-11-16 |
20170327535 | AFFINITY SEPARATION MATRIX FOR PURIFYING PROTEIN CONTAINING IMMUNOGLOBULIN K CHAIN VARIABLE REGION | 2017-11-16 |
20170327536 | NEUROTOXIC TARGET FOR AMYLOSPHEROID, METHOD AND MATERIAL FOR REDUCING THE NEUROTOXICITY OF AMYLOSPHEROID, AND USE THEREOF | 2017-11-16 |
20170327537 | BINDING LIGAND LINKED DRUG DELIVERY CONJUGATES OF TUBULYSINS | 2017-11-16 |
20170327538 | Peptide Inhibitors of Sodium Channels | 2017-11-16 |
20170327539 | Peptide and Complex of Same, Scaffold for Tissue Repair and Surface Treatment Method for Same, and Surface Treatment Solution or Set of Treatment Solutions | 2017-11-16 |
20170327540 | METHOD FOR ACYLATING A CYCLIC PEPTIDE | 2017-11-16 |
20170327541 | METHODS FOR SYNTHESIZING alpha4 7 PEPTIDE ANTAGONISTS | 2017-11-16 |
20170327542 | TEICOPLANIN ANALOGS AND USES THEREOF | 2017-11-16 |
20170327543 | POLYIONIC PAPILLOMA VIRUS-LIKE PARTICLE (VLP) VACCINES | 2017-11-16 |
20170327544 | RECOMBINANT VIRAL VECTORS | 2017-11-16 |
20170327545 | Modified Kappa Light Chain-Binding Polypeptides | 2017-11-16 |
20170327546 | Novel Insecticidal Proteins and Methods for Their Use | 2017-11-16 |
20170327547 | Novel Chimeric Insecticidal Proteins Toxic or Inhibitory to Lepidopteran Pests | 2017-11-16 |
20170327548 | Charged Nutritive Fragments, Proteins and Methods | 2017-11-16 |
20170327549 | Adenylation Enzyme Inhibitors | 2017-11-16 |
20170327550 | NBP158 AND USES THEREOF | 2017-11-16 |
20170327551 | METHODS OF USING COMPOSITIONS COMPRISING FUSION VARIANTS OF FGF19 POLYPEPTIDES FOR REDUCING GLUCOSE LEVELS IN A SUBJECT | 2017-11-16 |
20170327552 | PEPTIDES AND COMPOSITIONS FOR TREATMENT OF JOINT DAMAGE | 2017-11-16 |
20170327553 | COMPOSITIONS AND METHODS FOR LONG ACTING PROTEINS | 2017-11-16 |
20170327554 | CHEMOKINE-CYTOKINE FUSION PROTEINS AND THEIR APPLICATIONS | 2017-11-16 |
20170327555 | MOLECULES THAT SELECTIVELY ACTIVATE REGULATORY T CELLS FOR THE TREATMENT OF AUTOIMMUNE DISEASES | 2017-11-16 |
20170327556 | CARTILAGE-BINDING FUSION PROTEINS | 2017-11-16 |
20170327557 | Efficient delivery of therapeutic molecules to cells of the inner ear | 2017-11-16 |
20170327558 | MAMMALIAN CELL CULTURE PROCESSES FOR PROTEIN PRODUCTION | 2017-11-16 |
20170327559 | VIRAL INACTIVATION USING IMPROVED SOLVENT-DETERGENT METHOD | 2017-11-16 |
20170327560 | GDF15 FUSION PROTEINS AND USES THEREOF | 2017-11-16 |
20170327561 | Anti-Angiogenic Properties of Collagen V Derived Fragments | 2017-11-16 |
20170327562 | DESIGNER COLLAGENS AND USE THEREOF | 2017-11-16 |
20170327563 | Methods for Treating HIV-Associated Enteropathy Symptoms With Immunoglobulin/Protein Isolate | 2017-11-16 |
20170327564 | COMPOSITIONS AND METHODS FOR TREATMENT IN BROAD-SPECTRUM, UNDIFFERENTIATED OR MIXED CLINICAL APPLICATIONS | 2017-11-16 |
20170327565 | CROSS-PROTECTIVE PATHOGEN PROTECTION, METHODS AND COMPOSITIONS THEREOF | 2017-11-16 |
20170327566 | ANTI-ALPHA-SYNUCLEIN ANTIBODIES AND METHODS OF USE | 2017-11-16 |
20170327567 | COMBINATION OF ANTI-PD-1 ANTIBODIES AND RADIATION TO TREAT CANCER | 2017-11-16 |
20170327568 | ANTI-NGF COMPOSITIONS AND USE THEREOF | 2017-11-16 |
20170327569 | Novel Angiopoietin 2, VEGF Dual Antagonists | 2017-11-16 |
20170327570 | ANTI-TNF-alpha FULLY HUMAN MONOCLONAL ANTIBODIES WITH LOW IMMUNOGENICITY AND APPLICATION THEREOF | 2017-11-16 |
20170327571 | ANTI-HUMAN IL-17 MONOCLONAL ANTIBODIES AND USE THEREOF | 2017-11-16 |
20170327572 | TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE BY ANTAGONISM OF THE IL-20R | 2017-11-16 |
20170327573 | Composition to induce bone marrow stem cell mobilization | 2017-11-16 |
20170327574 | METHODS OF TREATING LIVER CONDITIONS USING NOTCH2 ANTAGONISTS | 2017-11-16 |
20170327575 | Folate Receptor 1 Antibodies and Immunoconjugates and Uses Thereof | 2017-11-16 |
20170327576 | ANTI P2X7 RECEPTOR ANTIBODIES AND FRAGMENTS THEREOF | 2017-11-16 |
20170327577 | METHODS OF CONSTRUCTING AMINO TERMINAL IMMUNOGLOBULIN FUSION PROTEINS AND COMPOSITIONS THEREOF | 2017-11-16 |
20170327578 | ANTI-CEACAM1 RECOMBINANT ANTIBODIES FOR CANCER THERAPY | 2017-11-16 |
20170327579 | BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND BCMA | 2017-11-16 |
20170327580 | BISPECIFIC ANTIBODIES AGAINST CD3 EPSILON AND BCMA FOR USE IN TREATMENT OF DISEASES | 2017-11-16 |
20170327581 | Anti-Leukocyte Adhesion for the Mitigation of Potential Adverse Events Caused by CD3-Specific Binding Domains | 2017-11-16 |
20170327582 | COMBINATION THERAPIES OF HDAC INHIBITORS AND PD-1 INHIBITORS | 2017-11-16 |
20170327583 | COMBINATION THERAPIES OF HDAC INHIBITORS AND PD-L1 INHIBITORS | 2017-11-16 |
20170327584 | Vedolizumab for the Treatment of Fistulizing Crohn's Disease | 2017-11-16 |
20170327585 | NOVEL EGFRVIII ANTIBODY AND COMPOSITION COMPRISING SAME | 2017-11-16 |
20170327586 | SYNERGISTIC COMBINATIONS OF OX40L ANTIBODIES FOR THE TREATMENT OF GVHD | 2017-11-16 |
20170327587 | ANTIBODIES, USES & METHODS | 2017-11-16 |
20170327588 | CD40L-Fc Fusion Polypeptides And Methods Of Use Thereof | 2017-11-16 |
20170327589 | ANTI-MESOTHELIN IMMUNOCONJUGATES AND USES THEREFOR | 2017-11-16 |
20170327590 | METHODS OF TREATING SKIN CANCER BY ADMINISTERING A PD-1 INHIBITOR | 2017-11-16 |
20170327591 | Diagnosis and Treatment of Cancer Expressing ILT3 or ILT3 Ligand | 2017-11-16 |
20170327592 | ANTIBODIES TO NON-FUNCTIONAL P2X7 RECEPTOR | 2017-11-16 |
20170327593 | METHOD FOR GENERATING HIGH AFFINITY ANTIBODIES | 2017-11-16 |
20170327594 | IgM and IgE Heavy Chain Domain 2 as Covalently Linked Homodimerization Modules for the Generation of Fusion Proteins with Dual Specificity | 2017-11-16 |
20170327595 | THERAPEUTIC AND DIAGNOSTIC METHODS RELATED TO LYSYL OXIDASE-LIKE 2 (LOXL2) | 2017-11-16 |
20170327596 | METHOD | 2017-11-16 |
20170327597 | RODENT BISPECIFIC HETERODIMERIC PROTEINS | 2017-11-16 |
20170327598 | SINGLE DOMAIN ANTIBODIES DIRECTED AGAINST INTRACELLULAR ANTIGENS | 2017-11-16 |
20170327599 | COMPOSITIONS AND METHODS FOR ENTRAPPING PROTEIN ON A SURFACE | 2017-11-16 |
20170327600 | RNA-PROTEIN COMPLEX, AND RNA AND PROTEIN DELIVERY SYSTEM USING THE SAME | 2017-11-16 |